文献速递胃肠外科围术期管理与 ERAS

微创结直肠手术价值新视角:支付方、提供方与患者获益

A new perspective on the value of minimally invasive colorectal surgery-payer, provider, and patient benefits.
PubMed 文献 · Surg Endosc · 2016-11-04

该研究基于2013年Truven MarketScan理赔数据,纳入4615例择期住院结肠切除术,比较开腹与微创手术的允许费用、并发症及再入院率。结果显示微创手术总允许费用显著低于开腹(37540美元 vs 45284美元,p<0.001),且开腹手术ICU使用率、并发症、住院时间及再入院率均更高。

要点

  • 微创结肠切除术总允许费用较开腹低7744美元/例,差异显著。
  • 开腹手术ICU使用率、总体并发症及结直肠特异性并发症均显著更高。
  • 开腹手术再入院率更高(11.54 vs 8.28/100例,p=0.0013)。

核心结论

  • 在商业保险人群中,微创结肠切除术的风险调整后允许费用显著低于开腹手术,每例差异近8000美元。

研究设计与样本

  • 基于Truven MarketScan理赔数据的回顾性分析,纳入2013年择期住院结肠切除术4615例,按ICD-9手术编码分为开腹(2054例,44.5%)与微创(2561例,55.5%)。

主要发现

  • 微创组总允许费用显著低于开腹组(37540美元 vs 45284美元,p<0.001)。
  • 开腹组ICU使用率(3.9% vs 2.0%,p<0.001)、总体并发症(52.8% vs 32.3%,p<0.001)、结直肠特异性并发症(32.5% vs 17.9%,p<0.001)均显著更高。
  • 开腹组住院时间更长(6.39天 vs 4.44天,p<0.001),首次住院费用更高(39585美元 vs 33183美元,p<0.001)。
  • 开腹组再入院率/100例更高(11.54 vs 8.28,p=0.0013),30天医疗费用更高(5699美元 vs 4357美元,p=0.0033)。
  • 开腹结肠切除术的净 episode 费用每例高出7744美元,即使DRG分布相似。

临床怎么用

  • 卫生计划和雇主可通过将结肠切除术从开腹转向微创来实现财务节省。
  • 在捆绑支付和责任医疗分享计划下,微创手术的成本影响可带来节约机会。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The clinical benefits of minimally invasive surgery (MIS) are proven, but overall financial benefits are not fully explored. Our goal was to evaluate the financial benefits of MIS from the payer's perspective to demonstrate the value of minimally invasive colorectal surgery. METHODS: A Truven MarketScan® claim-based analysis identified all 2013 elective, inpatient colectomies. Cases were stratified into open or MIS approaches based on ICD-9 procedure codes; then costs were assessed using a similar distribution across diagnosis related groups (DRGs). Care episodes were compared for average allowed costs, complication, and readmission rates after adjusting costs for demographics, comorbidities, and geographic region. RESULTS: A total of 4615 colectomies were included-2054 (44.5 %) open and 2561 (55.5 %) MIS. Total allowed episode costs were significantly lower MIS than open ($37,540 vs. $45,284, p < 0.001). During the inpatient stay, open cases had significantly greater ICU utilization (3.9 % open vs. 2.0 % MIS, p < 0.001), higher overall complications (52.8 % open vs. 32.3 % MIS, p < 0.001), higher colorectal-specific complications (32.5 % open vs. 17.9 % MIS, p < 0.001), longer LOS (6.39 open vs. 4.44 days MIS, p < 0.001), and higher index admission costs ($39,585 open vs. $33,183 MIS, p < 0.001). Post-discharge, open cases had significantly higher readmission rates/100 cases (11.54 vs. 8.28; p = 0.0013), higher average readmission costs ($3055 vs. $2,514; p = 0.1858), and greater 30-day healthcare costs than MIS ($5699 vs. $4357; p = 0.0033). The net episode cost of care was $7744/patient greater for an open colectomy, even with similar DRG distribution. CONCLUSIONS: In a commercially insured population, the risk-adjusted allowed costs for MIS colectomy episodes were significantly lower than open. The overall cost difference between MIS and open was almost $8000 per patient. This highlights an opportunity for health plans and employers to realize financial benefits by shifting from open to MIS for colectomy. With increasing bundled payment arrangements and accountable care sharing programs, the cost impact of shifting from open to MIS introduces an opportunity for cost savings.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Keller DS, Senagore AJ, Fitch K, et al. A new perspective on the value of minimally invasive colorectal surgery-payer, provider, and patient benefits. Surg Endosc. 2016. PMID: 27815745. doi:10.1007/s00464-016-5295-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。